CRISPR-based gene therapies are already changing healthcare for things like sickle cell disease. But CRISPR is bigger than just medicine, and it could revolutionize everything from food and agriculture to green energy fuels to...

CRISPR is a powerful gene editing tool, but its uses have been purely scientific until now. In 2023, US and UK drug regulators including the FDA approved Casgevy, a CRISPR/Cas9-based therapy for sickle cell disease and beta-thalassemia....

Has a doctor ever told you that you just have too much blood? Probably not, but there are a handful of conditions where being a little low might be good for you.

Lots of genetic diseases come down to a small change in a single gene, but how do you treat those diseases when the cells involved don’t have any DNA?

Sickle Cell Disease affects 100,00 Americans, and has been pretty well understood for a long time. So, why are there only two drugs available for the condition? Why are so few research dollars allocated to the problem? Well, the answers...

NSF's 2014 Alan T. Waterman Awardee Feng Zhang discusses the work of his research team on the brain. Zhang is an investigator at the McGovern Institute for Brain Research at MIT and a core member of the Broad Institute of MIT and...

Since 2002, more than 80 patients, mostly children, have been cured of sickle cell disease through stem cell transplant and gene therapy.

The Food and Drug Administration says there’s an unmet need for help for patients suffering from severe sickle cell anemia. A new drug that uses gene editing could solve that.

The Food and Drug Administration has approved two gene-editing treatments for patients 12 and older suffering from severe sickle cell disease, but they come with health risks doctors want patients to know about.

Gene therapies are considered miracle cures, but their exorbitant costs, which could exceed $12 billion, might hinder access for those in need. Bloomberg Opinion columnist Lisa Jarvis highlights how two gene therapies awaiting FDA...

CRISPR may be a cure, but clinical trials may lack volunteers because of black patients' mistrust of biased and unethical medical practices.

St. Thomas' Hospital, London, United Kingdom, 29th October 2008

1. Various of Princess Royal coming into room and unveiling plaque opening hospital
unit
2....

Beverley De Gale and Orin Lewis of the ACLT (African Caribbean Leukaemia Trust) speak about the launch of a new campaign, Bonded by Blood: A Mother’s Story, aimed at increasing blood donations from the black African, Caribbean and...

Mayor of London Sadiq Khan donates blood at City Hall donation drive, as part of a drive to encourage individuals from ethnic minority communities in London.



Mr Khan spoke at City Hall about the importance of these communities...